2025-07-20 - Analysis Report
Okay, here's an analysis of MSTY based on the provided data, presented in English with a focus on key figures and concise insights:

**MSTY Analysis - July 21, 2025**

**1. Performance Relative to S&P 500 (VOO)**

*   **Ticker:** MSTY (YieldMax MSTR Option Income Strategy ETF)
*   **Company Overview:** An ETF designed to generate income through options strategies on MicroStrategy (MSTR).
*   **MSTY Cumulative Return:** 45.75%
*   **VOO (S&P 500) Cumulative Return:** 24.57%
*   **Absolute Performance Difference:** 21.2% (MSTY outperformed VOO by 21.2% since inception)
*   **Relative Performance Index:** 52.2

    *   This means that MSTY's outperformance, relative to VOO, is currently positioned in the 52.2 percentile of its historical range.  While MSTY has outperformed, it's not at the peak of its relative outperformance.

*   **Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha | Beta   | Cap(B) |
|------------|--------|--------|-------|--------|--------|
| 2023-2025  | 46.0%  | 69.3%  | 21.0% | -0.1  | 4.1  |

    *   MSTY achieved a high CAGR of 46.0% between 2023 and 2025, with an Alpha of 21.0%, which means the ETF has generated returns exceeding what would be expected based on the market.
    *   The Beta of -0.1 suggests that MSTY is not highly correlated with the market, implying a potentially diversifying effect in a portfolio.
    *   However, the ETF experienced a substantial Maximum Drawdown (MDD) of 69.3%, indicating significant potential for losses.
    *   The fund has a Capitalization (Cap) of $4.1 billion.

**2. Recent Price Action**

*   **Current Price:** $21.68
*   **Last Market Data:**
    *   Price: $21.68
    *   Previous Close: $22.83
    *   Change: -5.04% (Significant drop)
*   **Moving Averages:**
    *   5-day MA: $22.47
    *   20-day MA: $21.58
    *   60-day MA: $22.29

    *   The price is currently below the 5-day and 60-day moving averages but is slightly above the 20-day moving average. The significant drop indicates a short-term bearish trend.

**3. Indicators**

*   **Market Risk Indicator (MRI):** 0.3399 (Low Risk)
*   **RSI:** 51.59 (Neutral)
*   **PPO:** 0.671 (Positive Momentum)
*   **Hybrid Signal:** Cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.33)
*   **20-day Relative Performance Divergence Change:** -5.0 (Negative - indicating recent underperformance relative to its comparison)
*   **Expected Return (%):** NaN (Not Available)

    *   Despite the price drop, the MRI suggests low market risk. RSI is neutral, while PPO indicates positive momentum, which might be a lagging indicator. The hybrid signal suggests buying 90% of cash. The large negative divergence suggests a recent short-term decline in relative performance.

**4. Recent News & Events**

*   **[2025-07-16]:** MSTY in headlines due to major business developments, regulatory changes, or market events.
*   **[2025-07-19]:** Analysts discussing MSTY's performance and outlook.
*   **[2025-07-18]:** MSTY stock showing notable volatility.
*   **[2025-07-20]:** Market experts highlight both risks and opportunities; advising monitoring.

    *   Recent news highlights volatility and significant events impacting MSTY. Analyst discussions and expert opinions suggest a need for careful monitoring.

**5. Overall Assessment**

MSTY has significantly outperformed the S&P 500 since inception, driven by its options strategy tied to MSTR. The recent price drop (-5.04%) and negative relative performance divergence are concerning and highlight the ETF's inherent volatility, as also emphasized by the MDD. The news further confirms recent volatility and impactful events. While the MRI indicates a low-risk environment, the high MDD and volatile news suggest that MSTY carries significant downside risk. Investors should monitor news, analyst opinions, and MSTR's performance closely before considering investment, especially given the significant price drop. The high historical CAGR, Alpha, and low Beta values suggest that MSTY can be a valuable addition to a portfolio, but risk-averse investors should be aware of the high MDD. The lack of an Expected Return estimate should also give potential investors pause, as it makes long-term planning uncertain.
